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•  Whole	  Genome	  Sequencing	  in	  support	  of	  
Wellness	  and	  Health	  Maintenance	  
•  Likelihood	  ra<os	  for	  genome	  medicine 
•  RGLM=random	  generalized	  linear	  model	  
•  Possible	  pipeline	  u<lizing	  the	  above	  methods	  
•  Family-­‐based	  associa<on	  studies	  on	  NGS	  data	  
•  An	  Efficient	  Sufficient	  Dimension	  Reduc<on	  
Method	  for	  Iden<fying	  Gene<c	  Variants	  of	  
Clinical	  Significance 
Whole	  Genome	  Sequencing	  in	  
support	  of	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  and	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Methods 
•  WGS	  &	  longitudinal	  clinical	  profiles	  of	  8	  ppl	  
(4+4)	  
•  Mul<variate	  genotypic	  risk	  assessments	  
(GWAS)	  I.E.	  Common	  variants	  
•  Clinical	  measurements	  :	  immune,	  metabolic,	  
cardiovascular,	  musculoskeletal,	  respiratory,	  
and	  mental	  health.	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Methods	  -­‐	  Cont. 
•  Non-­‐random	  picking	  of	  samples	  
•  Clinical	  Assessments	  
1)	  Health	  status	  assessments	  of	  interest,	  
2)	  Self-­‐reported	  family	  and	  personal	  medical	  history	  
•  WGS	  
1)	  Mean	  coverage=	  ~36X	  with	  95.5%	  (mean)	  >10X	  
2)	  87%	  of	  each	  individual’s	  quality	  filtered	  reads	  
were	  aligned	  
3)	  HiSeq2000	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•  Gene<c	  risk	  assessment	  (common	  variants)	  
1)  Gene<c	  risk	  predic<ons	  from	  VARIMED	  DB	  	  
2)  Combine	  odds	  ra<os	  of	  associated	  SNPs	  with	  diseases	  and	  
traits	  (LR	  Paper)	  
3)	  Loci	  with	  P-­‐value	  <	  10-­‐6	  &	  site	  in	  a	  haplotype	  block	  (r2	  >=	  0.8)	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Post	  test	  odds	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  paper 
Calcula&on	  of	  likelihood	  ra&os,	  and	  pre-­‐	  and	  post-­‐test	  probabili&es	  
	  
Likelihood	  ra<o	  =	  Probability	  of	  genotype	  in	  diseased	  person/Probability	  of	  
genotype	  in	  non-­‐diseased	  person	  	  
Likelihood	  ra<os	  mul<plied	  by	  the	  pre-­‐test	  odds	  of	  disease	  give	  the	  post-­‐test	  odds	  
of	  disease	  (Table	  1),	  and	  these	  likelihood	  ra<os	  may	  be	  chained	  together	  (Figure	  1):	  
	  
Pre-­‐test	  odds	  =	  Probability	  of	  disease/1	  -­‐	  Probability	  of	  disease	  
Pre-­‐test	  odds	  *	  LR1	  *	  LR2	  .….	  *LRn	  =	  Post-­‐test	  odds	  
	  
Post-­‐test	  probability	  =	  Post-­‐test	  odds/Post-­‐test	  odds	  +	  1 
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LR	  Paper	  –	  Interes<ng	  quotes 
Tradi<onally,	  the	  published	  literature	  on	  gene<c	  associa<ons	  has	  focused	  on	  
sugges<ng	  interes<ng	  variants	  with	  possible	  mechanis<c	  involvement	  in	  the	  disease	  of	  
study.	  Hence,	  authors	  may	  only	  report	  an	  odds	  ra<o	  as	  a	  measure	  of	  effect	  size,	  and	  a	  
P	  value	  to	  show	  that	  the	  variant	  is	  significantly	  associated	  with	  the	  disease.	  Many	  such	  
studies	  do	  not	  even	  report	  the	  risk	  genotype	  at	  the	  site	  of	  the	  SNP;	  this	  is	  a	  par<cular	  
problem	  because	  the	  rela<onship	  of	  the	  common	  allele	  in	  the	  popula<on	  under	  study	  
to	  a	  reference	  genome	  is	  unknown,	  and	  the	  reference	  genome	  may	  actually	  contain	  
the	  risk-­‐associated	  allele.	   
We	  recently	  curated	  2,174	  ar<cles	  repor<ng	  primary	  data	  on	  gene-­‐disease	  
associa<ons	  of	  variants	  in	  the	  Na<onal	  Center	  for	  Biotechnology	  Informa<on	  (NCBI)	  
SNP	  database	  (dbSNP)	  [20].	  Of	  these	  publica<ons,	  only	  46%	  contained	  informa<on	  on	  
actual	  genotype-­‐associated	  risk,	  enabling	  the	  calcula<on	  of	  a	  likelihood	  ra<o	  yielding	  a	  
total	  of	  2,092	  disease-­‐variant	  associa<	  .	  Although	  any	  par<cular	  gene<c	  associa<on	  
study	  may	  not	  be	  intended	  for	  use	  in	  informing	  a	  clinical	  diagnos<c	  test	  or	  
interpreta<on,	  informa<on	  on	  the	  actual	  propor<on/frequency	  of	  subjects	  with	  each	  
associated	  genotypic	  variant	  in	  the	  relevant	  phenotype	  categories	  (such	  as	  with	  and	  
without	  disease)	  should	  be	  made	  available	  for	  use	  in	  further	  studies	  and	  meta-­‐
analyses.	  This	  informa<on	  aids	  in	  a\empts	  at	  replica<on	  of	  results	  and	  in	  calcula<ng	  
overall	  es<mates	  of	  the	  power	  of	  a	  par<cular	  genotype	  to	  predict	  disease	  state.	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Methods	  –	  Cont.	  Clinical	  risk	  assessment 
•  1)	  5	  levels	  of	  risks	  regarding	  8	  different	  disease	  categories 
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Methods	  –	  Integra<on	  of	  gene<c	  and	  clinical	  data 
Directly	  matches	  GWAS	  results	  
with	  individual	  diseases 
•  average	  Framingham	  risk	  scores	  
(FRS)	  for	  each	  person	  at	  each	  visit	  
across	  the	  en<re	  CHDWB	  database	  
•  post-­‐test	  probability=pre-­‐test	  
probability	  *	  LR/(1+(pre-­‐test	  
probability*(LR-­‐1)))	  
•  Limita<ons:	  
•  no	  appropriate	  clinical	  biomarkers	  
for	  some	  diseases	  in	  our	  cohort	  
•  Some	  are	  precisely	  the	  
endophenotype	  of	  the	  disease/
traits	  inves<gated	  in	  GWAS	  
(Redundant) 
Combines	  mul&ple	  clinical	  and	  
gene&c	  measures 
•  generate	  an	  overall	  portrait	  of	  
risk	  in	  eight	  major	  disease	  
categories	  
•  The	  z-­‐scores	  for	  clinical	  
parameters	  are	  adjusted	  with	  
respect	  to	  risk	  predisposi<on:	  
for	  traits	  which	  are	  known	  to	  
confer	  risk	  at	  a	  lower	  level	  
•  gene<c	  risk	  scores	  are	  ranked	  
according	  to	  percen<les	  into	  
five	  categories	  
Results	  -­‐	  Cont. 
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Results	  –	  Method1 
(A)	  (B)	  standard	  format;	  (C)	  (D)	  risk-­‐o-­‐grams	  adjusted	  according	  to	  observed	  clinical	  risk.	  Gender	  and	  age-­‐specific	  disease	  
prevalence	  for	  Caucasians	  are	  indicated	  by	  the	  black	  triangles	  (or	  hash	  marks	  in	  lower	  panels).	  Genotypic	  effects	  are	  
predicted	  to	  increase	  (right	  point)	  or	  decrease	  (let	  point)	  overall	  risk	  by	  the	  indicated	  magnitude	  (orange	  or	  purple,	  
respec<vely),	  resul<ng	  in	  the	  indicated	  rank-­‐ordered	  overall	  risk.	  The	  number	  of	  SNPs	  used	  in	  the	  computa<on	  for	  each	  
disease	  is	  indicated	  to	  the	  right.	  The	  adjusted	  risk-­‐o-­‐grams	  according	  to	  observed	  clinical	  risk	  (C	  and	  D)	  either	  increases	  (red	  
triangle)	  or	  decreases	  (green	  triangle)	  the	  baseline	  without	  affec<ng	  the	  genotypic	  component,	  but	  results	  in	  adjustment	  of	  
overall	  risk	  and	  rank	  order.	  Note	  that	  CHD-­‐5	  is	  a	  woman,	  and	  CHD-­‐8	  a	  man,	  so	  breast	  and	  prostate	  cancer	  are	  indicated	  for	  
each	  as	  appropriate. 
(A)	  Metabolic	  risk	  showing	  joint	  genotypic	  likelihood	  ra<os	  for	  Obesity	  (OB),	  Type	  2	  Diabetes	  (T2D),	  and	  
Hypertriglyceridemia	  (HTG)	  as	  bars,	  and	  related	  clinical	  measures	  as	  the	  indicated	  points,	  for	  each	  of	  
the	  8	  individuals	  in	  the	  study.	  (B)	  Similar	  Cardiovascular	  risk	  assessments	  for	  Hypertension	  (HTN),	  
Myocardial	  Infarc<on	  (MI),	  and	  Coronary	  Artery	  Disease	  (CAD)	  as	  bars,	  along	  with	  related	  clinical	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(C)	  Proposal	  for	  “Gridiron	  Plot”	  representa<on	  of	  clinical	  risk	  (y-­‐axis)	  against	  genotypic	  risk	  (z-­‐axis)	  in	  eight	  disease	  domains	  
described	  in	  the	  text,	  for	  individual	  CHD-­‐5.	  The	  plot	  gives	  a	  glimpse	  of	  where	  the	  two	  types	  of	  assessment	  are	  concordant	  
(eg	  CVD,	  cardiovascular)	  or	  discordant	  (IMM,	  immunological),	  and	  more	  refined	  analyses	  such	  as	  in	  panels	  (A)	  and	  (B)	  
provide	  further	  clues	  as	  to	  the	  gene<c	  basis	  of	  overall	  risk. 
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